本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NovoCure Limited

11.27
-0.3400-2.93%
盤後11.280.0100+0.09%19:07 EST
成交量:122.18萬
成交額:1,387.28萬
市值:12.62億
市盈率:-7.01
高:11.50
開:11.48
低:11.24
收:11.61
52周最高:34.13
52周最低:10.87
股本:1.12億
流通股本:9,414.79萬
量比:0.70
換手率:1.30%
股息:- -
股息率:- -
每股收益(TTM):-1.6074
每股收益(LYR):-1.5638
淨資產收益率:-50.60%
總資產收益率:-8.30%
市淨率:3.70
市盈率(LYR):-7.21

資料載入中...

2025/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/09/15

重要事件披露

Form 8-K - Current report
2025/08/28

重要事件披露

Form 8-K - Current report
2025/07/24

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/24

重要事件披露

Form 8-K - Current report
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/06

重要事件披露

Form 8-K - Current report
2025/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/24

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/24

重要事件披露

Form 8-K - Current report
2025/04/22

重要事件披露

Form 8-K - Current report